TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
| Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
| SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
| Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
| Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
| Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
| Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
| COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |